Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 14 of 14 publications.

Leonard C, Bhogal P, Menon AP, Ling C, Mordin M. HTA requirements for medical technologies in Spain. Poster to be given at the ISPOR Europe 2024; November 17, 2024. Barcelona, Spain.

Menon AP, Villanueva H, Meraviglia-Crivelli D, van Santen HM, Hellmeier J, Zheleva A, Nonateli F, Peters T, Wachsmann TLA, Hernandez-Rueda M, Huppa JB, Schutz GJ, Sevcsik E, Moreno B, Pastor F. CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer. Mol Ther Nucleic Acids. 2024 Apr 23;35(2):102198. doi: 10.1016/j.omtn.2024.102198

Menon AP, Moreno B, Meraviglia-Crivelli D, Nonatelli F, Villanueva H, Barainka M, Zheleva A, van Santen HM, Pastor F. Modulating T cell responses by targeting CD3. Cancers. 2023 Feb 13;15(4):1189. doi: 10.3390/cancers15041189

Meraviglia-Crivelli D, Villanueva H, Zheleva A, Villalba-Esparza M, Moreno B, Menon AP, Calvo A, Cebollero J, Barainka M, de Los Mozos IR, Huesa-Berral C, Pastor F. IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction. Mol Cancer. 2022 Nov 28;21(1):211. doi: 10.1186/s12943-022-01679-6

Meraviglia-Crivelli D, Villanueva H, Menon AP, Zheleva A, Moreno B, Villalba-Esparza M, Pastor F. A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression. Mol Ther Nucleic Acids. 2022 Jul 20;29:413-25. doi: 10.1016/j.omtn.2022.07.017

Huang L, Bommireddy R, Munoz LE, Guin RN, Wei C, Ruggieri A, Menon AP, Li X, Shanmugam M, Owonikoko TK, Ramalingam SS, Selvaraj P. Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor. PLoS One. 2021 Aug 19;16(8):e0254125. doi: 10.1371/journal.pone.0254125

Sola M, Menon AP, Moreno B, Meraviglia-Crivelli D, Soldevilla MM, Carton-Garcia F, Pastor F. Aptamers against live targets: is in vivo SELEX finally coming to the edge? Mol Ther Nucleic Acids. 2020 Sep 4;21:192-204. doi: 10.1016/j.omtn.2020.05.025

Soldevilla MM, Villanueva H, Meraviglia-Crivelli D, Menon AP, Ruiz M, Cebollero J, Villalba M, Moreno B, Lozano T, Llopiz D, Pejenaute A, Sarobe P, Pastor F. ICOS costimulation at the tumor site in combination with CTLA-4 blockade therapy elicits strong tumor immunity. Mol Ther. 2019 Nov 6;27(11):1878-91. doi: 10.1016/j.ymthe.2019.07.013

Bommireddy R, Huang HL, Munoz LE, Menon AP, Ramalingam S, Selvaraj P. Immunotherapy with tumor membrane vesicle-based cancer vaccine inhibits metastatic tumor growth in lung cancer model. Poster presented at the Immunology 2019 Meeting; May 9, 2019. San Diego, CA. [abstract] J Immunol. 2019 May 1; 202(1_Supplement):70.7. doi: 10.4049/jimmunol.202.Supp.70.7

Soldevilla MM, Meraviglia-Crivelli de Caso D, Menon AP, Pastor F. Aptamer-iRNAs as therapeutics for cancer treatment. Pharmaceuticals (Basel). 2018 Oct 18;11(4):108. doi: 10.3390/ph11040108

Soldevilla MM, Villanueva H, Martinez-Velez N, Meraviglia-Crivelli D, Alonso MM, Cebollero J, Menon AP, Puigdelloses M, Pastor F. Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors. Oncoimmunology. 2018 Apr 9;7(8):e1450711. doi: 10.1080/2162402X.2018.1450711

Bommireddy R, Pack CD, Bozeman EN, Patel JM, Vartebedian VF, Munoz LE, Shafizadeh Y, Menon AP, Lakshmanan R, Reddy SJC, Selvaraj P. Membrane-based immunotherapy with immune checkpoint blockade antibodies confers protection against metastatic breast cancer. Poster presented at the Immunology 2017 Meeting; May 12, 2017. Washington, DC. [abstract] J Immunol. 2017 May 1; 198(1_Supplement):120.8. doi: 10.4049/jimmunol.198.Supp.120.8

Munoz LE, Bommireddy R, Margaroli C, Shafizadeh Y, Bozeman EN, Menon AP, Kumar J, Lakshmanan R, Selvaraj P. HER-2+ breast cancer cells expressing GPI-anchored cytokines induce long lasting antitumor memory response. Poster presented at the Immunology 2017 Meeting; May 12, 2017. Washington, DC. [abstract] J Immunol. 2017 May 1; 198(1_Supplement):79.28. Previously presented at the International Congress of Immunology (ICI) 2016. doi: 10.4049/jimmunol.198.Supp.79.28

Bommireddy R, Margaroli C, Shafizadeh Y, Bozeman E, Munoz L, Menon A, Selvaraj P. HER-2+ breast cancer cells expressing GPI-anchored cytokines induce long lasting anti-tumor memory response. Poster presented at the International Congress of Immunology (ICI) 2016; August 21, 2016. Melbourne, Australia. [abstract] Eur J Immunol. 2016 Aug; 46(Suppl. 1):227. doi: 10.1002/eji.201670200